抗肺结核药物联合痰热清注射液治疗老年肺结核的临床效果  

Clinical effect of anti-tuberculosis drugs combined with Tanreqing injection in the treatment of senile pulmonary tuberculosis

作　　者：方富盛 FANG Fusheng(Huilai County Chronic Disease Prevention and Treatment Station,Jieyang 515200,China)

机构地区：[1]惠来县慢性病防治站,广东揭阳515200

出　　处：《临床医学研究与实践》2020年第30期144-145,共2页Clinical Research and Practice

摘　　要：目的研究抗肺结核药物联合痰热清注射液治疗老年肺结核的临床效果。方法将60例老年肺结核患者按照就诊顺序随机分对照组(n=30,常规抗结核治疗)与观察组(n=30,常规抗结核治疗+痰热清注射液)。比较两组的治疗效果。结果治疗后,两组IL-6及TNF-α水平均低于治疗前,且观察组低于对照组(P<0.05)。观察组的治疗总有效率高于对照组(P<0.05)。观察组的不良反应总发生率低于对照组(P<0.05)。结论抗肺结核药物联合痰热清注射液治疗老年肺结核患者,能减轻炎症反应,提高疗效,降低不良反应发生率。Objective To study the clinical effect of anti-tuberculosis drugs combined with Tanreqing injection in the treatment of senile pulmonary tuberculosis.Methods Sixty elderly patients with pulmonary tuberculosis were randomly divided into control group(n=30,routine anti-tuberculosis treatment)and observation group(n=30,routine anti-tuberculosis treatment+Tanreqing injection)according to the order of doctors'office visiting.The therapeutic effects of the two groups were compared.Results After treatment,the levels of IL-6 and TNF-αin the two groups were lower than those before treatment,and those in the observation group were lower than the control group(P<0.05).The total effective rate of treatment in the observation group was higher than that in the control group(P<0.05).The total incidence of adverse reactions in the observation group was lower than that in the control group(P<0.05).Conclusion Anti-tuberculosis drugs combined with Tanreqing injection in the treatment of elderly patients with pulmonary tuberculosis can reduce the inflammatory reaction,improve the curative effect and reduce the incidence of adverse reactions.

关 键 词：老年肺结核 抗肺结核药物 痰热清注射液 

分 类 号：R521[医药卫生—内科学]